Aspira Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Aspira Womans' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Aspira Womans in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
2 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aspira Womans. Your research has to be compared to or analyzed against Aspira Womans' peers to derive any actionable benefits. When done correctly, Aspira Womans' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Aspira Womans Health.

Aspira Womans Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aspira Womans and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Aspira and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aspira Womans Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Aspira Womans Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Aspira Womans stock performing well and Aspira Womans company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Aspira Womans' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
At Risk
A 1.93  0.17  0.07  0.12  2.26  0.07 (2.10)  4.22 (3.29)  9.78 
AKU 3.45 (0.44)  0.00 (0.36)  0.00 (0.09)  0.00  9.80 (7.55)  21.74 
ANIX 4.02  0.40  0.07  0.26  5.36  0.07 (4.06)  8.13 (9.09)  25.80 
SBUX 1.89  0.28  0.11  0.17  2.13  0.1 (1.92)  4.12 (4.21)  14.93 
NFLX 3.06  0.28  0.07  0.13  3.57  0.07 (3.32)  7.35 (6.35)  14.89 
FWRD 1.70  0.15  0.06  0.10  2.41  0.06 (1.69)  4.23 (3.39)  13.23 
MTOR 0.13  0.02  0.19  0.69  0.00  0.18 (0.16)  0.42 (0.25)  0.83 
AMTD 11.60  3.65  0.44 (1.67)  6.42  0.11 (19.19)  18.18 (11.30)  267.74 
LEA 2.40  0.16  0.05  0.09  3.09  0.05 (2.35)  5.12 (4.90)  14.13 
MGAM 27,404,059  15,985,695  0.00  168,270  0.00  0.38  0.00  111,899,900 (33.51)  111,899,934 

Cross Equities Net Income Analysis

Compare Aspira Womans Health and related stocks such as Agilent Technologies, Akumin Inc, Anixa Biosciences, Starbucks Corp, Netflix, Foward Air Corp, Meritor, Amtd Idea Group, Lear Corp, and Mobile Global Esports Net Income Over Time
Select Fundamental

AB1.2 B734 M549 M401 M462 M684 M316 M1.1 B719 M1.2 B1.4 B1.2 B
AKUMMMMMMMMM(11.3 M)(36.7 M)(43.3 M)(44.4 M)
ANIX(7.4 M)(4.3 M)(10.1 M)(9.6 M)(1.4 M)(5 M)(5 M)(14 M)(11.6 M)(10 M)(13 M)(11.7 M)(12.6 M)
SBUX2.9 B2.9 B2.9 B2.9 B2.9 B2.9 B2.9 B4.2 B4.2 B4.2 B4.2 B4.5 B4.9 B
NFLX160.9 M226.1 M17.2 M112.4 M266.8 M122.6 M186.7 M558.9 M1.2 B1.9 B2.8 B5.1 B5.5 B
FWRD47.2 M47.2 M52.7 M54.5 M61.2 M55.6 M27.5 M87.3 M92.1 M87.1 M23.7 M105.9 M92.3 M
MTOR63 M52 M(22 M)249 M64 M573 M324 M117 M291 M245 M199 M228.8 M233.9 M
AMTD568.3 M568.3 M568.3 M568.3 M568.3 M568.3 M568.3 M568.3 M468.1 M938.3 M1.1 B1.1 B1.1 B
LEA540.7 M540.7 M1.3 B431.4 M672.4 M745.5 M975.1 M1.3 B1.1 B753.6 M158.5 M373.9 M518.2 M
MGAM5.7 M28.2 M34.9 M31.9 M31.9 M31.9 M31.9 M31.9 M31.9 M31.9 M31.9 M36.7 M33.9 M

Aspira Womans Health and related stocks such as Agilent Technologies, Akumin Inc, Anixa Biosciences, Starbucks Corp, Netflix, Foward Air Corp, Meritor, Amtd Idea Group, Lear Corp, and Mobile Global Esports Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Aspira Womans Health financial statement analysis. It represents the amount of money remaining after all of Aspira Womans Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Aspira Womans Competitive Analysis

The better you understand Aspira Womans competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aspira Womans' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aspira Womans' competition over several years is one of the best ways to analyze its investment potential.
 Better Than Average     
 Worse Than Peers    View Performance Chart
Amtd Idea
Lear Corp
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Potential Upside
Treynor Ratio
Maximum Drawdown
Market Risk Adjusted Performance
Risk Adjusted Performance
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Aspira Womans Competition Performance Charts

Complement your Aspira Womans position

In addition to having Aspira Womans in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Climate Change Thematic Idea Now

Climate Change
Climate Change Theme
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Aspira Womans Correlation with its peers. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
105.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

USD 0.94  0.04  4.08%   

Aspira Womans Health competes with Agilent Technologies, Akumin, Anixa Biosciences, Starbucks Corp, and Netflix; as well as few others. The company runs under null sector within null industry. Analyzing Aspira Womans competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aspira Womans to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aspira Womans competition on your existing holdings. Please continue to Aspira Womans Correlation with its peers.
The current Return on Investment is estimated to decrease to -145.7. The current Return on Average Assets is estimated to decrease to -0.66. Aspira Womans Total Assets Per Share are most likely to slightly decrease in the upcoming years. The last year's value of Total Assets Per Share was reported at 0.37. The current Asset Turnover is estimated to increase to 0.18, while Total Assets are projected to decrease to roughly 32.6 M.